INCHANGE - Nintedanib for Changes in Cough and Dyspnea in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease With a Progressive Phenotype in Everyday Clinical Practice: a Real-world Evaluation
Clinical trial NCT05151640 · COMPLETED
Trial details
- NCT number
- NCT05151640
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-02-08
- Primary completion
- 2025-09-05
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.